JuB significantly inhibited the tumor growth compared to the control group, as illustrated in Fig. 5A. At the end of the test (day 15), the tumor volume with JuB treatment was 339.8 mm3, 55.5% less than in the control group (763.1 mm3). This evidence concerns the gene AJUBA and neoplasm.